Serveur d'exploration sur l'Indium

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Transcapillary exchange of indium 111-labeled anticardiac myosin Fab and thallium 201 in isolated reperfused rabbit hearts

Identifieur interne : 000142 ( Main/Exploration ); précédent : 000141; suivant : 000143

Transcapillary exchange of indium 111-labeled anticardiac myosin Fab and thallium 201 in isolated reperfused rabbit hearts

Auteurs : RBID : ISTEX:12350_1994_Article_BF02940337.pdf

English descriptors

Abstract

BackgroundThe physiologic mechanisms of111In-labeled anticardiac myosin antibody [111In]-AM) imaging are fairly well established. However, to better understand the transcapillary exchange characteristics of normal and reperfused myocardium, a standard first-pass, indicator-dilution analysis was undertaken in hearts subjected to global no-flow and low-flow ischemia.Methods and ResultsThe first-pass myocardial transport of201Tl and [111In]-AM was evaluated in an in vitro rabbit model of no-flow ischemia/reperfusion with indicator-dilution analysis during normal and ischemic flows and whole-blood perfusate. The maximum extraction fraction (Emax) of201Tl was dominated by flow rate as expected and averaged 0.75 (±0.009) and 0.57 (±0.008) during ischemic and normal flows, respectively (p<0.01). Emax values for [111In]-AM, which were 0.02 or less in all hearts at control, increased to 0.06 or greater at moderate to longer perfusion times after 50 or more minutes of no-flow ischemia. Permeability surface area (in milliliters per minute per gram) tended to decline for201Tl with longer reperfusion periods in both ischemic and normal flow groups and paralleled the changes observed for Emax for [111In]-AM.ConclusionsThese data demonstrate that the first-pass extraction of [111In]-AM is quite low in this model of acute coronary occlusion and reflow and enhanced only in severe ischemia-reperfusion treatment. Therefore in this model there appears to be no significant [111In]-AM uptake in either normal or mildly ischemic myocardium. Consequently, [111In]-AM uptake into myocardium must depend on tracer recirculation, as well as sarcolemmal cell wall disruption, to achieve specific and sufficient [111In]-AM uptake for localization of clinical imaging.

DOI: 10.1007/BF02940337

Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title>Transcapillary exchange of indium 111-labeled anticardiac myosin Fab and thallium 201 in isolated reperfused rabbit hearts</title>
<author>
<name>Denis J. Meerdink</name>
<affiliation>
<mods:affiliation>From the Department of Physiology and Pharmacology, Myocardial Research Laboratory, School of Pharmacy, University of the Pacific, 95211, Stockton, CA, </mods:affiliation>
<wicri:noCountry code="subField"></wicri:noCountry>
</affiliation>
<affiliation>
<mods:affiliation>the Departments of Nuclear Medicine and Medicine, Division of Cardiology, Myocardial Isotope Research Laboratory, University of Massachusetts Medical Center, Worcester, Mass., </mods:affiliation>
<wicri:noCountry code="subField"></wicri:noCountry>
</affiliation>
</author>
<author>
<name>Jeffrey A. Leppo</name>
<affiliation>
<mods:affiliation>From the Department of Physiology and Pharmacology, Myocardial Research Laboratory, School of Pharmacy, University of the Pacific, 95211, Stockton, CA, </mods:affiliation>
<wicri:noCountry code="subField"></wicri:noCountry>
</affiliation>
<affiliation>
<mods:affiliation>the Departments of Nuclear Medicine and Medicine, Division of Cardiology, Myocardial Isotope Research Laboratory, University of Massachusetts Medical Center, Worcester, Mass., </mods:affiliation>
<wicri:noCountry code="subField"></wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="RBID">ISTEX:12350_1994_Article_BF02940337.pdf</idno>
<date when="1994">1994</date>
<idno type="doi">10.1007/BF02940337</idno>
<idno type="wicri:Area/Main/Corpus">000C98</idno>
<idno type="wicri:Area/Main/Curation">000C98</idno>
<idno type="wicri:Area/Main/Exploration">000142</idno>
</publicationStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antimyosin</term>
<term>First-pass extraction</term>
<term>Indicator dilution</term>
<term>Isolated rabbit heart</term>
<term>Reperfusion</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="eng">BackgroundThe physiologic mechanisms of111In-labeled anticardiac myosin antibody [111In]-AM) imaging are fairly well established. However, to better understand the transcapillary exchange characteristics of normal and reperfused myocardium, a standard first-pass, indicator-dilution analysis was undertaken in hearts subjected to global no-flow and low-flow ischemia.Methods and ResultsThe first-pass myocardial transport of201Tl and [111In]-AM was evaluated in an in vitro rabbit model of no-flow ischemia/reperfusion with indicator-dilution analysis during normal and ischemic flows and whole-blood perfusate. The maximum extraction fraction (Emax) of201Tl was dominated by flow rate as expected and averaged 0.75 (±0.009) and 0.57 (±0.008) during ischemic and normal flows, respectively (p<0.01). Emax values for [111In]-AM, which were 0.02 or less in all hearts at control, increased to 0.06 or greater at moderate to longer perfusion times after 50 or more minutes of no-flow ischemia. Permeability surface area (in milliliters per minute per gram) tended to decline for201Tl with longer reperfusion periods in both ischemic and normal flow groups and paralleled the changes observed for Emax for [111In]-AM.ConclusionsThese data demonstrate that the first-pass extraction of [111In]-AM is quite low in this model of acute coronary occlusion and reflow and enhanced only in severe ischemia-reperfusion treatment. Therefore in this model there appears to be no significant [111In]-AM uptake in either normal or mildly ischemic myocardium. Consequently, [111In]-AM uptake into myocardium must depend on tracer recirculation, as well as sarcolemmal cell wall disruption, to achieve specific and sufficient [111In]-AM uptake for localization of clinical imaging.</div>
</front>
</TEI>
<mods xsi:schemaLocation="http://www.loc.gov/mods/v3 file:///applis/istex/home/loadistex/home/etc/xsd/mods.xsd" version="3.4" istexId="e0e2ac53cfd8d748f6079e75bf5db88d66a1fdba">
<titleInfo lang="eng">
<title>Transcapillary exchange of indium 111-labeled anticardiac myosin Fab and thallium 201 in isolated reperfused rabbit hearts</title>
</titleInfo>
<name type="personal">
<namePart type="given">Denis J.</namePart>
<namePart type="family">Meerdink</namePart>
<namePart type="termsOfAddress">PhD</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
<affiliation>From the Department of Physiology and Pharmacology, Myocardial Research Laboratory, School of Pharmacy, University of the Pacific, 95211, Stockton, CA, </affiliation>
<affiliation>the Departments of Nuclear Medicine and Medicine, Division of Cardiology, Myocardial Isotope Research Laboratory, University of Massachusetts Medical Center, Worcester, Mass., </affiliation>
</name>
<name type="personal">
<namePart type="given">Jeffrey A.</namePart>
<namePart type="family">Leppo</namePart>
<namePart type="termsOfAddress">MD</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
<affiliation>From the Department of Physiology and Pharmacology, Myocardial Research Laboratory, School of Pharmacy, University of the Pacific, 95211, Stockton, CA, </affiliation>
<affiliation>the Departments of Nuclear Medicine and Medicine, Division of Cardiology, Myocardial Isotope Research Laboratory, University of Massachusetts Medical Center, Worcester, Mass., </affiliation>
</name>
<typeOfResource>text</typeOfResource>
<genre>Original Articles</genre>
<genre>Original Paper</genre>
<originInfo>
<publisher>Springer-Verlag, New York</publisher>
<dateCreated encoding="w3cdtf">1993-11-05</dateCreated>
<dateCaptured encoding="w3cdtf">1994-01-18</dateCaptured>
<dateValid encoding="w3cdtf">2008-08-27</dateValid>
<copyrightDate encoding="w3cdtf">1994</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
</physicalDescription>
<abstract lang="eng">BackgroundThe physiologic mechanisms of111In-labeled anticardiac myosin antibody [111In]-AM) imaging are fairly well established. However, to better understand the transcapillary exchange characteristics of normal and reperfused myocardium, a standard first-pass, indicator-dilution analysis was undertaken in hearts subjected to global no-flow and low-flow ischemia.Methods and ResultsThe first-pass myocardial transport of201Tl and [111In]-AM was evaluated in an in vitro rabbit model of no-flow ischemia/reperfusion with indicator-dilution analysis during normal and ischemic flows and whole-blood perfusate. The maximum extraction fraction (Emax) of201Tl was dominated by flow rate as expected and averaged 0.75 (±0.009) and 0.57 (±0.008) during ischemic and normal flows, respectively (p<0.01). Emax values for [111In]-AM, which were 0.02 or less in all hearts at control, increased to 0.06 or greater at moderate to longer perfusion times after 50 or more minutes of no-flow ischemia. Permeability surface area (in milliliters per minute per gram) tended to decline for201Tl with longer reperfusion periods in both ischemic and normal flow groups and paralleled the changes observed for Emax for [111In]-AM.ConclusionsThese data demonstrate that the first-pass extraction of [111In]-AM is quite low in this model of acute coronary occlusion and reflow and enhanced only in severe ischemia-reperfusion treatment. Therefore in this model there appears to be no significant [111In]-AM uptake in either normal or mildly ischemic myocardium. Consequently, [111In]-AM uptake into myocardium must depend on tracer recirculation, as well as sarcolemmal cell wall disruption, to achieve specific and sufficient [111In]-AM uptake for localization of clinical imaging.</abstract>
<subject lang="eng">
<genre>Key Words</genre>
<topic>antimyosin</topic>
<topic>reperfusion</topic>
<topic>indicator dilution</topic>
<topic>first-pass extraction</topic>
<topic>isolated rabbit heart</topic>
</subject>
<relatedItem type="series">
<titleInfo type="abbreviated">
<title>J. Nucl. Cardiol.</title>
</titleInfo>
<titleInfo>
<title>Journal of Nuclear Cardiology</title>
<partNumber>Year: 1994</partNumber>
<partNumber>Volume: 1</partNumber>
<partNumber>Number: 3</partNumber>
</titleInfo>
<genre>Archive Journal</genre>
<originInfo>
<dateIssued encoding="w3cdtf">1994-05-01</dateIssued>
<copyrightDate encoding="w3cdtf">1994</copyrightDate>
</originInfo>
<subject usage="primary">
<topic>Medicine & Public Health</topic>
<topic>Nuclear Medicine</topic>
<topic>Cardiology</topic>
<topic>Imaging / Radiology</topic>
</subject>
<identifier type="issn">1071-3581</identifier>
<identifier type="issn">Electronic: 1532-6551</identifier>
<identifier type="matrixNumber">12350</identifier>
<identifier type="local">IssueArticleCount: 12</identifier>
<recordInfo>
<recordOrigin>American Society of Nuclear Cardiology, 1994</recordOrigin>
</recordInfo>
</relatedItem>
<identifier type="doi">10.1007/BF02940337</identifier>
<identifier type="matrixNumber">Art3</identifier>
<identifier type="local">BF02940337</identifier>
<accessCondition type="use and reproduction">MetadataGrant: OpenAccess</accessCondition>
<accessCondition type="use and reproduction">AbstractGrant: OpenAccess</accessCondition>
<accessCondition type="restriction on access">BodyPDFGrant: Restricted</accessCondition>
<accessCondition type="restriction on access">BodyHTMLGrant: Restricted</accessCondition>
<accessCondition type="restriction on access">BibliographyGrant: Restricted</accessCondition>
<accessCondition type="restriction on access">ESMGrant: Restricted</accessCondition>
<part>
<extent unit="pages">
<start>236</start>
<end>245</end>
</extent>
</part>
<recordInfo>
<recordOrigin>American Society of Nuclear Cardiology, 1994</recordOrigin>
<recordIdentifier>12350_1994_Article_BF02940337.pdf</recordIdentifier>
</recordInfo>
</mods>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000142 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000142 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:12350_1994_Article_BF02940337.pdf
   |texte=   Transcapillary exchange of indium 111-labeled anticardiac myosin Fab and thallium 201 in isolated reperfused rabbit hearts
}}

Wicri

This area was generated with Dilib version V0.5.81.
Data generation: Mon Aug 25 10:35:12 2014. Site generation: Thu Mar 7 10:08:40 2024